DOI QR코드

DOI QR Code

A Case of Vancomycin-Resistant Enterococci Infection Treated with Korean Medicine

반코마이신 내성 장구균 감염 환자에 대한 한의치험 1례

  • Dabin Lee (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Siyun Sung (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Sunghee Hong (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Ye-chae Hwang (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Gyeongmuk Kim (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Han-Gyul Lee (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Sang-Kwan Moon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Woo-Sang Jung (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University) ;
  • Seungwon Kwon (Dept. of Clinical Korean Medicine, Graduate School, Kyung Hee University)
  • 이다빈 (경희대학교 대학원 임상한의학과) ;
  • 성시윤 (경희대학교 대학원 임상한의학과) ;
  • 홍성희 (경희대학교 대학원 임상한의학과) ;
  • 황예채 (경희대학교 대학원 임상한의학과) ;
  • 김경묵 (경희대학교 대학원 임상한의학과) ;
  • 이한결 (경희대학교 대학원 임상한의학과) ;
  • 문상관 (경희대학교 대학원 임상한의학과) ;
  • 정우상 (경희대학교 대학원 임상한의학과) ;
  • 권승원 (경희대학교 대학원 임상한의학과)
  • Received : 2024.04.17
  • Accepted : 2024.05.29
  • Published : 2024.05.30

Abstract

Hospital-acquired bacterial infections, including vancomycin-resistant enterococci (VRE) infection (MIC: 32 mcg/ml), are common. We describe the case of a 63-year-old female patient with subarachnoid hemorrhage and VRE infection treated with Jashin-bowon-tang and Samhuang-sashim-tang for 57 days and 22 days, respectively. The therapeutic effect was assessed weekly via culture, color and viscosity of pus from a coccyx sore, and C-reactive protein (CRP). Vital signs were checked four times a day. Seventeen days after treatment, VRE was not colonized in patient and color and viscosity of pus, CRP and vital sign were improved. This case report suggests that Jashin-bowon-tang and Samhuang-sashim-tang might be an alternative option for VRE infection patients reducing the need for extended isolation periods and speeding up recovery times.

Keywords

References

  1. Humphries R, Bobenchik AM, Hindler JA, Schuetz AN. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100. Journal of clinical microbiology 2021;59(12):10.1128/jcm. 00213-21.
  2. Bonten MJ, Slaughter S, Ambergen AW, Hayden MK, van Voorhis J, Nathan C, et al. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch Intern Med 1998;158(10):1127-32.
  3. Olivier CN, Blake RK, Steed LL, Salgado CD. Risk of Vancomycin-Resistant Enterococcus (VRE) Bloodstream Infection Among Patients Colonized With VRE. Infection Control & Hospital Epidemiology 2008;29(5):404-9.
  4. Morgan DJ, Kaye KS, Diekema DJ. Reconsidering isolation precautions for endemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus. Jama 2014;312(14):1395-6.
  5. Suh WJ, Kim GM, Seo YN, Cho KH, Moon SK, Jung WS, et al. Effect of Bojungikki-tang-gami (Bu Zhong Yi Qi Tang) on the Clearance of Vancomycin-resistant Enterococci Colonization in Patients with Cerebral Nerve Disease: A Case Series. The Journal of Internal Korean Medicine 2019;40(5):974-82.
  6. Jumah Muhammed Taufiq B, Vasoo S, Menon Sanjay R, De Partha P, Neely M, Teng Christine B. Pharmacokinetic/Pharmacodynamic Determinants of Vancomycin Efficacy in Enterococcal Bacteremia. Antimicrobial Agents and Chemotherapy 2018;62(3):10.1128/aac.01602-17.
  7. Nakakura I, Sakakura K, Imanishi K, Sako R, Yamazaki K. Association between vancomycin pharmacokinetic/pharmacodynamic parameters, patient characteristics, and mortality in patients with bacteremia caused by vancomycin-susceptible Enterococcus faecium: a single-center retrospective study. Journal of Pharmaceutical Health Care and Sciences 2019;5(1):8.
  8. Jenkins I. Linezolid-and vancomycin-resistant Enterococcus faecium endocarditis: successful treatment with tigecycline and daptomycin. Journal of hospital medicine. 2007;2(5):343.
  9. Vinh DC, Rubinstein E. Linezolid: a review of safety and tolerability. Journal of Infection 2009;59 Suppl 1:S59-S74.
  10. Seo HJ, Bae GE, Choi JY, Shim SH, Seo HB, Han CW, et al. A Case Report of a Stroke Patient with Vancomycin-Resistant Enterococci Colonization Treated with Korean Medicine, Especially Gami-sipjeondaebo-tang. J Int Korean Med 2018;39(5):939-48.
  11. Reynolds PE, Arias CA, Courvalin P. Gene vanXYC encodes D,D -dipeptidase (VanX) and D,D-carboxypeptidase (VanY) activities in vancomycin-resistant Enterococcus gallinarum BM4174. Mol Microbiol 1999;34(2):341-9.
  12. Ostrowsky BE, Trick WE, Sohn AH, Quirk SB, Holt S, Carson LA, et al. Control of vancomycin-resistant enterococcus in health care facilities in a region. N Engl J Med 2001;344(19):1427-33.
  13. Gandra S, Barysauskas CM, Mack DA, Barton B, Finberg R, Ellison RT. Impact of contact precautions on falls, pressure ulcers and transmission of MRSA and VRE in hospitalized patients. Journal of Hospital Infection 2014;88(3):170-6.
  14. Eichel VM, Last K, Bruhwasser C, von Baum H, Dettenkofer M, Gotting T, et al. Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis. Journal of Hospital Infection 2023;141:119-28.
  15. Wells CL, Juni BA, Cameron SB, Mason KR, Dunn DL, Ferrieri P, et al. Stool Carriage, Clinical Isolation, and Mortality During an Outbreak of Vancomycin-Resistant Enterococci in Hospitalized Medical and/or Surgical Patients. Clinical Infectious Diseases 1995;21(1):45-50.
  16. Lee JW, Kim YS, Lee DS. A Study of New Herbal Medicine Prescription for the Treatment of Dermatological Diseases. Food Industry and Nutrition 2021;26(2):36-43.
  17. Sun L, Han Y. Effect of the Modified Baoyuan Tang on Macrophage Phagocytosid in Restrained Stress Mice. Chinese Mental Health Journal 1988;12.
  18. Xiao-jing M, Lan W, Yin L, Ying L, Lei-lei G, Yong-qing X, et al. Study on Efficacy and Mechanisms of Antipyretic of Sanhuangxiexin Decoction by Processing Compatibility. Chinese Journal of Pharmacovigilance 2016;13(8):449.
  19. Wang Z, Yi T, Long M, Gao Y, Cao C, Huang C, et al. Electro-acupuncture at Zusanli acupoint (ST36) suppresses inflammation in allergic contact dermatitis via triggering local IL-10 production and inhibiting p38 MAPK activation. Inflammation 2017;40(4):1351-64.
  20. Guo J, Tang W, Guo F, Yang L, Wang J, Fu G, et al. Transcutaneous electrical acupoint stimulation on inflammatory response and intestinal permeability in perioperative period of laparoscopic intestinal surgery. Zhongguo Zhen jiu=Chinese Acupuncture & Moxibustion 2018;38(10):1043-6.